A detailed history of Clarius Group, LLC transactions in Danaher Corp stock. As of the latest transaction made, Clarius Group, LLC holds 4,537 shares of DHR stock, worth $1.08 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,537
Previous 4,685 3.16%
Holding current value
$1.08 Million
Previous $1.17 Million 7.78%
% of portfolio
0.09%
Previous 0.08%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$239.25 - $280.76 $35,409 - $41,552
-148 Reduced 3.16%
4,537 $1.26 Million
Q2 2024

Jul 11, 2024

SELL
$235.51 - $267.98 $33,913 - $38,589
-144 Reduced 2.98%
4,685 $1.17 Million
Q1 2024

Apr 17, 2024

SELL
$224.58 - $256.19 $175,396 - $200,084
-781 Reduced 13.92%
4,829 $1.21 Million
Q4 2023

Jan 29, 2024

SELL
$185.1 - $233.13 $73,114 - $92,086
-395 Reduced 6.58%
5,610 $1.3 Million
Q3 2023

Oct 19, 2023

SELL
$233.08 - $265.59 $406,491 - $463,188
-1,744 Reduced 22.51%
6,005 $1.49 Million
Q2 2023

Aug 09, 2023

BUY
$224.99 - $256.14 $11,024 - $12,550
49 Added 0.64%
7,749 $1.86 Million
Q1 2023

Apr 17, 2023

SELL
$239.75 - $277.0 $109,565 - $126,589
-457 Reduced 5.6%
7,700 $1.94 Million
Q4 2022

Jan 25, 2023

SELL
$241.42 - $282.29 $39,110 - $45,730
-162 Reduced 1.95%
8,157 $2.17 Million
Q3 2022

Oct 24, 2022

BUY
$247.06 - $1507.4 $104,259 - $636,122
422 Added 5.34%
8,319 $2.15 Million
Q2 2022

Aug 10, 2022

BUY
$237.11 - $299.66 $123,060 - $155,523
519 Added 7.03%
7,897 $2 Million
Q4 2021

Feb 02, 2022

BUY
$292.08 - $329.01 $42,059 - $47,377
144 Added 1.99%
7,378 $2.43 Million
Q3 2021

Oct 18, 2021

BUY
$272.21 - $332.43 $34,570 - $42,218
127 Added 1.79%
7,234 $2.2 Million
Q2 2021

Aug 06, 2021

BUY
$225.08 - $271.69 $18,681 - $22,550
83 Added 1.18%
7,107 $1.91 Million
Q1 2021

Apr 27, 2021

BUY
$212.38 - $245.9 $43,325 - $50,163
204 Added 2.99%
7,024 $1.58 Million
Q4 2020

Jan 15, 2021

BUY
$212.5 - $245.46 $80,750 - $93,274
380 Added 5.9%
6,820 $1.52 Million
Q3 2020

Oct 09, 2020

BUY
$177.16 - $215.33 $531 - $645
3 Added 0.05%
6,440 $1.39 Million
Q2 2020

Jul 08, 2020

BUY
$128.7 - $176.83 $54,053 - $74,268
420 Added 6.98%
6,437 $1.14 Million
Q1 2020

Apr 24, 2020

BUY
$121.39 - $169.05 $100,632 - $140,142
829 Added 15.98%
6,017 $833,000
Q4 2019

Jan 22, 2020

SELL
$133.47 - $153.48 $68,603 - $78,888
-514 Reduced 9.01%
5,188 $834,000
Q3 2019

Oct 23, 2019

BUY
$135.4 - $146.47 $122,266 - $132,262
903 Added 18.82%
5,702 $824,000
Q2 2019

Aug 02, 2019

BUY
$124.88 - $143.73 $34,466 - $39,669
276 Added 6.1%
4,799 $686,000
Q1 2019

May 14, 2019

BUY
$97.62 - $132.29 $246,685 - $334,296
2,527 Added 126.6%
4,523 $597,000
Q4 2018

Feb 11, 2019

BUY
$94.85 - $109.54 $189,320 - $218,641
1,996 New
1,996 $206,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $173B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Clarius Group, LLC Portfolio

Follow Clarius Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.